1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep)

1 º Congresso Mundial sobre Controvérsias em Gestão da hepatite viral (hepatite C)

Dates: May 19-22, 2011
Location: Barcelona, Spain

Endorsed by the AGA Institute.

Register by Jan. 26, 2011 and save on your registration fee.

Overview

Join leading experts in the field of viral hepatitis as they address state-of-the-art management issues in order to outline the optimal treatment for patients. The program includes ample time for faculty-attendee interaction to discuss unresolved issues and find solutions to ongoing challenges even when the data in this area remains limited.

Preliminary program highlights:

• Who has hepatitis C in 2011?
• Hepatitis B: Any controversies left?
• Direct antivirals: The future is now.
• First line therapy: Are there preferred options?
• Is there still a need to access liver damage? Pro/Con.
• Does drug resistance testing have a clinical role in HCV? Pro/Con.
• Frequent viral load monitoring: necessity or luxury?
• Liver biopsies: End of the game? 
• HBV Therapy in 2011.
• Clinical Cases.
• Hemoglobinopathies.
• Is Hepatitis B curable?
• Liver transplantation in 2011.
• The future is now.
 

Download preliminary program.

 

Posters for Young Investigators

Submission deadline: March 1, 2011

Investigators under the age of 40 may submit a poster on their scientific insights into HCV treatment. Successful posters may be selected for an award or a participation grant. All posters will be presented at the congress and published on the congress Web site. Posters will be reviewed and assessed by the congress scientific review committee based on scientific content and impact. Learn more.

More Information

For more information and to register, please visit the conference Web site at http://www.comtecmed.com/chep/2011/.

Date: 19 to 22 May 2011 Data: 19 a 22 maio de 2011
Location: Barcelona, Spain Local: Barcelona, Espanha




1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) 1 º Congresso Mundial sobre Controvérsias em Gestão da hepatite viral (hepatite C)